Pavimol Angsantikul, PhD

Technical Area Focus:
Formulation development and testing; drug delivery; GMP manufacturing

Dr. Angsantikul leads the translational drug delivery laboratory at CBR. The laboratory conducts preclinical and early clinical development and designs manufacturing processes of pharmaceutical products for novel sexual and reproductive health interventions. Dr. Angsantikul’s expertise in biomedical engineering and nanotechnology have led to the development of bioinspired and translational platforms, including natural cell-mimicking nanoparticles for targeted antibiotic delivery; cell receptor-functionalized nanoparticles for bacterial toxin neutralization; active micromotor-enabled oral drug delivery; and nanoparticle-hydrogel hybrid system for topical delivery. Dr. Angsantikul holds a BEng in Nano Engineering from Chulalongkorn University, Thailand, a PhD in Nano Engineering from the University of California, San Diego.